Tesorx Pharma L L C
USPTO Trademark & Patent Filings
Trademark applications and grants for Tesorx Pharma L L C. Tesorx Pharma L L C has 27 trademark applications. The latest application filed is for "O"
| Patent Application | Date |
|---|---|
| PROLIPOSOMAL TESTOSTERONE UNDECANOATE FORMULATIONS 20220265679 - 17/631525 KADAJJI; Veeran Gowda ; et al. | 2022-08-25 |
| LIPOSOMAL ENHANCED INTRA-PERITONEAL CHEMOTHERAPY 20220000777 - 17/290329 OEFELEIN; Michael G. ; et al. | 2022-01-06 |
| FORMULATIONS FOR TREATING BLADDER CANCER 20210267896 - 17/324584 BETAGERI; Guru V. ; et al. | 2021-09-02 |
| LIPOSOMAL PACLITAXEL FORMULATION FOR TREATING BLADDER CANCER 20200170993 - 16/631566 OEFELEIN; Michael G. ; et al. | 2020-06-04 |
| METHODS OF TREATING UPPER TRACT UROTHELIAL CARCINOMAS 20190343763 - 16/348801 BETAGERI; Guru V. ; et al. | 2019-11-14 |
| SEC | 0001554258 | TesoRx Pharma, LLC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 